Blistex Dct 4.5 % (Oxybenzone OINTMENT) 4.5 %

Blistex DCT 4.5% Ointment provides topical relief for cold sores and fever blisters. This 7g jar contains oxybenzone, a key ingredient for managing lip irritation. Ideal for quick, targeted application.

Strength

4.5 %

Pack Size

7G/JAR

Manufacturer / TM Owner

BLISTEX CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Blistex DCT 4.5% Ointment is primarily used for the treatment of cold sores and fever blisters. It helps to soothe and protect irritated skin on the lips. Many people ask, 'What is Blistex DCT used for?'—it's designed to provide relief from discomfort and promote healing.

Side Effects

When applied, Blistex DCT 4.5% Ointment may create a protective barrier over the affected area, helping to reduce irritation and discomfort. Users often notice a soothing effect, which can aid in the healing process of cold sores and fever blisters.

Precautions & Warnings

Before using Blistex DCT 4.5% Ointment, it's important to read the label for any warnings or precautions. Avoid contact with eyes and mucous membranes. If irritation occurs, discontinue use and consult a healthcare professional.

Avoid Interactions

Blistex DCT 4.5% Ointment is a topical treatment, so interactions with other medications are generally minimal. However, it's always wise to inform your healthcare provider about all products you are using, especially if you have known allergies or sensitivities.

Frequently Asked Questions

Blistex DCT 4.5% Ointment is used to treat cold sores and fever blisters, providing relief and promoting healing.

Apply a thin layer of the ointment directly to the affected area as needed. Follow the instructions on the label for best results.

If you have sensitive skin, perform a patch test before full application. Discontinue use if irritation occurs.

Consult a healthcare professional before using Blistex DCT 4.5% Ointment on children to ensure it is appropriate for their needs.

The time it takes for Blistex DCT 4.5% Ointment to work can vary. Some users may experience relief shortly after application, while others may need consistent use over several days.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.